Trade Name | Hokoen Pharmaceutical Co., Ltd | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Address | 134-5, Hama 8 Bancho, Utazucho, Ayauta-gun, Kagawa, 769-0208 Japan | |||||||||||
Founded on | April 1, 1950 | |||||||||||
Established on | July 1, 1960 | |||||||||||
Capital fund | 48,000,000 yen | |||||||||||
Representative | President and Chief Executive Officer Takanobu Hamada | |||||||||||
Approved Business Categories | Medical product marketing business Quasi-drug manufacturing and marketing business Medical apparatus manufacturing and marketing business Cosmetic product manufacturing and marketing / manufacturing business Whole sale distribution business |
|||||||||||
Business Contents | ■Manufacturing and marketing General pharmaceutical products, quasi-drug products, medical equipment, cosmetic products, health food, health-related articles, etc. Contract manufacturing Pharmaceutical products, quasi-drug products, medical equipment, cosmetic equipment, health food, etc. |
|||||||||||
Offices |
|
|||||||||||
|
||||||||||||
|
Message from the President
Hokoen Pharmaceutical Co., Ltd has manufactured and marketed pharmaceutical products, quasi drug products, medical apparatuses, health food, and cosmetic products, and contract manufactures related products, since its foundation in 1950.
We are responsible for sufficiently consider the security and safety of each product, in genuine consideration of the greatest desire to stay healthy. We have acquired the Health Food GMP adaptation approval, because if we continue or renovate the production control system based on technology development, strict quality control, and process control, we can continue to acquire trust in our products and from customers. These efforts are of course made every day.
QOL, health life improvement, and self-medication are considered to draw more attention as Japan enters into a super-aging society. As a company which contributes to the fields of "health and beauty", we want to grow in synergy with consumers and transaction customers, providing products responsive to domestic situations and demands of the current age.
To create an affluent society now and in the future, we will fulfill our corporate social responsibility (CSR) and continue to devote ourselves more intensively to this end.
We will proactively collaborate with overseas companies with which we have not been able to have an involvement thus far. We will development our business on a global scale, aiming to be a World Standard company increasing our current status as a Japan Standard company.
President and Chief Executive Officer Takanobu Hamada